CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)
Balance at Dec. 31, 2022	$ 40,209	$ 211	$ 98,306	$ (58,198)	$ (110)
Balance (in shares) at Dec. 31, 2022		21,093,000
Issuance of unrestricted stock		$ 1	(1)
Issuance of unrestricted stock (in shares)		62,000
Shares surrendered by employees to pay taxes related to unrestricted stock	(15)		(15)
Shares surrendered by employees to pay taxes related to unrestricted stock (in shares)		(9,000)
Repurchase of common stock	(341)	$ (2)	(339)
Repurchase of common stock (in shares)		(191,000)
Stock-based compensation expense	335		335
Other comprehensive income (loss)	147				147
Net Income (Loss)	(1,568)			(1,568)
Balance at Mar. 31, 2023	38,767	$ 210	98,286	(59,766)	37
Balance (in shares) at Mar. 31, 2023		20,955,000
Balance at Dec. 31, 2022	40,209	$ 211	98,306	(58,198)	(110)
Balance (in shares) at Dec. 31, 2022		21,093,000
Net Income (Loss)	(3,075)
Balance at Sep. 30, 2023	37,865	$ 210	98,976	(61,273)	(48)
Balance (in shares) at Sep. 30, 2023		21,018,000
Balance at Mar. 31, 2023	38,767	$ 210	98,286	(59,766)	37
Balance (in shares) at Mar. 31, 2023		20,955,000
Issuance of common stock under employee stock purchase plan	52	$ 1	51
Issuance of common stock under employee stock purchase plan (in shares)		38,000
Stock-based compensation expense	403		403
Other comprehensive income (loss)	(128)				(128)
Net Income (Loss)	(2,651)			(2,651)
Balance at Jun. 30, 2023	36,443	$ 211	98,740	(62,417)	(91)
Balance (in shares) at Jun. 30, 2023		20,993,000
Issuance of common stock under employee stock purchase plan	2		2
Issuance of common stock under employee stock purchase plan (in shares)		106,000
Repurchase of common stock	(126)	$ (1)	(125)
Repurchase of common stock (in shares)		(81,000)
Stock-based compensation expense	359		359
Other comprehensive income (loss)	43				43
Net Income (Loss)	1,144			1,144
Balance at Sep. 30, 2023	37,865	$ 210	98,976	(61,273)	(48)
Balance (in shares) at Sep. 30, 2023		21,018,000
Balance at Dec. 31, 2023	$ 34,298	$ 210	99,405	(65,512)	195
Balance (in shares) at Dec. 31, 2023	21,017,892	21,018,000
Issuance of unrestricted stock		$ 2	(2)
Issuance of unrestricted stock (in shares)		67,000
Stock-based compensation expense	$ 164		164
Other comprehensive income (loss)	(56)				(56)
Net Income (Loss)	(982)			(982)
Balance at Mar. 31, 2024	33,424	$ 212	99,567	(66,494)	139
Balance (in shares) at Mar. 31, 2024		21,085,000
Balance at Dec. 31, 2023	$ 34,298	$ 210	99,405	(65,512)	195
Balance (in shares) at Dec. 31, 2023	21,017,892	21,018,000
Net Income (Loss)	$ (3,239)
Balance at Sep. 30, 2024	$ 31,891	$ 212	100,057	(68,751)	373
Balance (in shares) at Sep. 30, 2024	21,194,071	21,194,000
Balance at Mar. 31, 2024	$ 33,424	$ 212	99,567	(66,494)	139
Balance (in shares) at Mar. 31, 2024		21,085,000
Issuance of common stock under employee stock purchase plan	40		40
Issuance of common stock under employee stock purchase plan (in shares)		28,000
Stock-based compensation expense	243		243
Other comprehensive income (loss)	(16)				(16)
Net Income (Loss)	(1,090)			(1,090)
Balance at Jun. 30, 2024	32,601	$ 212	99,850	(67,584)	123
Balance (in shares) at Jun. 30, 2024		21,113,000
Issuance of unrestricted stock		$ 1	(1)
Issuance of unrestricted stock (in shares)		86,000
Shares surrendered by employees to pay taxes related to unrestricted stock	(13)	$ (1)	(12)
Shares surrendered by employees to pay taxes related to unrestricted stock (in shares)		(5,000)
Stock-based compensation expense	220		220
Other comprehensive income (loss)	250				250
Net Income (Loss)	(1,167)			(1,167)
Balance at Sep. 30, 2024	$ 31,891	$ 212	$ 100,057	$ (68,751)	$ 373
Balance (in shares) at Sep. 30, 2024	21,194,071	21,194,000